November 12, 2025 — Leads & Copy — Bioceres Crop Solutions Corp. (Bioceres) (NASDAQ: BIOX) announced its financial results for the first fiscal quarter, which ended Sept. 30, 2025. The results, expressed in U.S. dollars, align with International Financial Reporting Standards. All comparisons are year-over-year unless noted otherwise.
Total revenues for 1Q26 reached $77.5 million, a 17% year-over-year decline, which Bioceres attributes to the seed model transition and reduced low-margin sales. Gross profit was $36.2 million, a 3% decrease from last year, but the gross margin expanded from 40% to 47% due to a more profitable product mix.
The operating profit for the quarter was $7.1 million, with a net loss of $7.5 million, and an adjusted EBITDA of $13.6 million. The operating profit and adjusted EBITDA increased by 200% and 61% year-over-year, respectively, reflecting margin expansion and cost discipline. Working capital continued to improve both year-over-year and sequentially.
According to Bioceres’ Chief Executive Officer Federico Trucco, the quarter reflects clear progress on the priorities set for the year: improving the quality of revenues, protecting margins, and operating with discipline. Trucco stated that profitability improved and costs continued to decrease as the company reduced exposure to low-margin activities and focused on a more efficient product mix.
Trucco noted that while Argentina remains challenging, conditions are showing early signs of normalization. The company is prioritizing actions that strengthen its capital structure and enhance financial flexibility. The company aims to focus on margin quality, cost discipline, and working-capital efficiency, while positioning itself for long-term resilience.
Key Financial Metrics for 1Q26 (millions of U.S. dollars):
- Crop Protection: $39.9 million (1Q25: $47.7 million)
- Seed and Integrated Products: $12.6 million (1Q25: $19.8 million)
- Crop Nutrition: $25.1 million (1Q25: $25.7 million)
- Total Revenue: $77.5 million (1Q25: $93.2 million)
- Gross Profit: $36.2 million (1Q25: $37.5 million)
- Gross Margin: 46.7% (1Q25: 40.2%)
- GAAP Net income or loss: -$7.5 million (1Q25: -$6.2 million)
- Adjusted EBITDA: $13.6 million (1Q25: $8.5 million)
Revenues totaled $77.5 million in 1Q26, a 17% decline versus the prior year. Bioceres attributes the revenue performance to the planned reduction of low-margin and working-capital-intensive sales and the impact of timing of sales in certain Latam markets, particularly Uruguay.
Despite lower revenues, operating performance strengthened, supported by a more profitable product mix and lower operating expenses. The gross margin expanded from 40% to 47%, and SG&A expenses decreased year-over-year, reflecting restructuring initiatives and cost discipline.
The net loss was $7.5 million, compared to a loss of $6.2 million in 1Q25. Higher financial costs and increased tax accruals led to a wider bottom-line loss. Adjusted EBITDA was $13.6 million, a 61% increase versus $8.5 million in 1Q25.
Management will host a conference call and question-and-answer session on Thursday, November 13, 2025, at 8:30 a.m. EST. A replay of the call will be available through November 20, 2025.
Bioceres Crop Solutions Corp. (NASDAQ: BIOX) develops and commercializes productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change.
For more information, visit here.
Source: Bioceres Crop Solutions Corp.
